
Ottawa biotech firm Avivagen closes $5.3M financing amid U.S. market push
An Ottawa-based biotech firm that makes a line of natural health products designed to replace antibiotics in livestock feed has announced a multimillion-dollar funding round
Ottawa biotech firm Avivagen closes $5.3M financing amid U.S. market push
An Ottawa-based biotech firm that makes a line of natural health products designed to replace antibiotics in livestock feed has announced a multimillion-dollar funding round
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Help Shape the Future of Ottawa’s Historic ByWard Market: Apply to Join the BMDA Board of Directors
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall